Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04125134 · ClinicalTrials.gov registry record · Phase 4
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
A Phase 4 study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT04125134 is a Phase 4 study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 36 participants.
The verdict
NCT04125134, a Phase 4 study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a single site, prospective, cross-sectional, controlled clinical study on a total of 66 subjects. The subjects are divided into two groups: Hypertonic Saline Non-Responders (33 subjects) and Hypertonic Saline Responders (33 subjects). After completion of questionnaires, the subjects will undergo Dry Eye Disease testing and functional nerve testing. Subjects who qualify will be dispensed 4 weeks of preservative free artificial tears and instructed to instill one drop into each eye twice daily. Subjects will return for a follow up visit 4 weeks later (± 4 days), during which subjects will complete the questionnaires again and the Dry Eye Disease tests and functional nerve tests will be repeated.
Interventions
- DRUG Preservative-free Refresh Optive Advanced Lubricant Eye Drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-10-03 |
| Est. Completion | 2025-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04125134
The ClinicalTrials.gov registry entry for NCT04125134 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preservative-free Refresh Optive Advanced Lubricant Eye Drops is the first listed.
NCT04125134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04125134 about?
NCT04125134 is a clinical study titled "Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests". This is a single site, prospective, cross-sectional, controlled clinical study on a total of 66 subjects. The subjects are divided into two groups: Hypertonic Saline Non-Responders (33 subjects) and Hypertonic Saline Responders (33 subjects). After completion of questionnaires, the subjects will und...
What is the current status of trial NCT04125134?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2019-10-03. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT04125134?
The interventions under investigation include: Preservative-free Refresh Optive Advanced Lubricant Eye Drops (DRUG).
Who is sponsoring clinical trial NCT04125134?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.